RAR and RXR modulation in cancer and metabolic disease

Proposals for the Classification of the Acute Leukaemias F rench ‐A merican ‐B ritish (FAB) C o‐operative G roup

Bennett, J. M., Catovsky, D., Mt, D., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,595 · see citing works

Epigenetics in human disease and prospects for epigenetic therapy

Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232 · see citing works

Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia

Bennett, J. M., Catovsky, D., Daniel, M., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,940 · see citing works

The polycomb group protein EZH2 is involved in progression of prostate cancer

Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717 · see citing works

The history of cancer epigenetics

Feinberg, A. P., & Tycko, B. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1279 · Cited by 2,350 · see citing works

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

Fraga, M. F., Ballestar, E., Villar‐Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C. E., Ropero, S., Petrie, K. R., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,926 · see citing works

Histone deacetylases and cancer: causes and therapies

Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866 · see citing works

Molecular basis of sun-induced premature skin ageing and retinoid antagonism

Fisher, G. J., Datta, S. C., Talwar, H. S., Wang, Z.-Q., Varani, J., Kang, S., & Voorhees, J. J. (1996) · Nature · doi:10.1038/379335a0 · Cited by 1,410 · see citing works

Principles for modulation of the nuclear receptor superfamily

Gronemeyer, H., Gustafsson, J.-Å., & Laudet, V. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1551 · Cited by 1,228 · see citing works

Role of the histone deacetylase complex in acute promyelocytic leukaemia

Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,060 · see citing works

Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia

Grignani, F., Matteis, S. D., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004 · see citing works

Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators

Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931 · see citing works

hDOT1L Links Histone Methylation to Leukemogenesis

Okada, Y., Feng, Q. F., Lin, Y.-H., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., & Zhang, Y. (2005) · Cell · doi:10.1016/j.cell.2005.02.020 · Cited by 819 · see citing works

Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor

Croce, L. D., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo‐Coco, F., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 786 · see citing works

The Biology of Peroxisome Proliferator-Activated Receptors

Ferré, P. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s43 · Cited by 778 · see citing works

The promise of retinoids to fight against cancer

Altucci, L., & Gronemeyer, H. (2001) · Nature Reviews Cancer · doi:10.1038/35106036 · Cited by 773 · see citing works

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors

Huntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697 · see citing works

Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors

Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680 · see citing works

Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer

Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637 · see citing works

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Álvarez, R., Schiavone, E. M., Ferrara, F., Bresciani, F., et al. (2004) · Nature Medicine · doi:10.1038/nm1161 · Cited by 613 · see citing works

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

Mukherjee, R., Davies, P. J., Crombie, D. L., Bischoff, E. D., Cesario, R. M., Jow, L., Hamann, L. G., Boehm, M. F., Mondon, C. E., Nadzan, A. M., et al. (1997) · Nature · doi:10.1038/386407a0 · Cited by 598 · see citing works

FUNCTION OF RETINOID NUCLEAR RECEPTORS: Lessons from Genetic and Pharmacological Dissections of the Retinoic Acid Signaling Pathway During Mouse Embryogenesis

Mark, M. P., Ghyselinck, N. B., & Chambon, P. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141156 · Cited by 596 · see citing works

Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL

He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 555 · see citing works

Histone deacetylase (HDAC) inhibitor activation of p21 WAF1 involves changes in promoter-associated proteins, including HDAC1

Gui, C., Ngo, L., Xu, W., Richon, V. M., & Marks, P. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307708100 · Cited by 550 · see citing works

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

Insinga, A., Monestiroli, S., Ronzoni, S., Gelmetti, V., Marchesi, F., Viale, A., Altucci, L., Nervi, C., Minucci, S., & Pelicci, P. G. (2004) · Nature Medicine · doi:10.1038/nm1160 · Cited by 512 · see citing works

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

Warrell, R. P., He, L.-Z., Richon, V., Calleja, E., & Pandolfi, P. P. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1621 · Cited by 502 · see citing works

Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development

Takeda, K., Smyth, M. J., Cretney, E., Hayakawa, Y., Kayagaki, N., Yagita∥, H., & Okumura, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011171 · Cited by 462 · see citing works

Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer

Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M. M., Englaro, W., Schoonjans, K., Dérijard, B., Desvergne, B., Wahli, W., Chambon, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.827 · Cited by 458 · see citing works

Identification of XAF1 as an antagonist of XIAP anti-Caspase activity

Liston, P., Fong, W. G., Kelly, N. L., Toji, S., Miyazaki, T., Conte, D., Tamai, K., Craig, C. G., McBurney, M. W., & Korneluk, R. G. (2001) · Nature Cell Biology · doi:10.1038/35055027 · Cited by 441 · see citing works

Expression of DNA methyltransferases DNMT1,3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia

Mizuno, S., Chijiwa, T., Okamura, T., Akashi, K., Fukumaki, Y., Niho, Y., & Sasaki, H. (2001) · Blood · doi:10.1182/blood.v97.5.1172 · Cited by 439 · see citing works

Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene

Bachman, K. E., Park, B. H., Rhee, I. P., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 419 · see citing works

Retinoid X Receptor Heterodimers in the Metabolic Syndrome

Shulman, A. I., & Mangelsdorf, D. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043590 · Cited by 380 · see citing works

PML regulates p53 stability by sequestering Mdm2 to the nucleolus

Bernardi, R., Scaglioni, P. P., Bergmann, S., Horn, H. F., Vousden, K. H., & Pandolfi, P. P. (2004) · Nature Cell Biology · doi:10.1038/ncb1147 · Cited by 348 · see citing works

Crystal structure of the human RXRα ligand‐binding domain bound to its natural ligand: 9‐cis retinoic acid

Egea, P. F., Mitschler, A., Rochel, N., Ruff, M., Chambon, P., & Moras, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2592 · Cited by 343 · see citing works

SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia

Hong, S.-H., David, G., Wong, C.-W., Dejean, A., & Privalsky, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9028 · Cited by 341 · see citing works

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL

Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C., & Gronemeyer, H. (2001) · Nature Medicine · doi:10.1038/89050 · Cited by 340 · see citing works

Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor γ Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues

Way, J. M., Harrington, W. W., Brown, K. K., Gottschalk, W. K., Sundseth, S. S., Mansfield, T. A., Ramachandran, R. K., Willson, T. M., & Kliewer, S. A. (2001) · Endocrinology · doi:10.1210/endo.142.3.8037 · Cited by 338 · see citing works

Cytoplasmic PML function in TGF-β signalling

Lin, H., Bergmann, S., & Pandolfi, P. P. (2004) · Nature · doi:10.1038/nature02783 · Cited by 312 · see citing works

PML Is a Direct p53 Target that Modulates p53 Effector Functions

de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312 · see citing works

Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes

Yamauchi, T., Waki, H., Kamon, J., Murakami, K., Motojima, K., Komeda, K., Miki, H., Kubota, N., Terauchi, Y., Tsuchida, A., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12864 · Cited by 304 · see citing works

Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia

He, L.-Z., Tolentino, T., Grayson, P. C., Zhong, S., Warrell, R. P., Rifkind, R. A., Marks, P. A., Richon, V. M., & Pandolfi, P. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111537 · Cited by 303 · see citing works

Transcriptional Activation of the Human p21 Gene by Retinoic Acid Receptor

Liu, M., Iavarone, A., & Freedman, L. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31723 · Cited by 300 · see citing works

v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid.

Leder, A., Kuo, A. C., Cardiff, R. D., Sinn, E., & Leder, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9178 · Cited by 293 · see citing works

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor

Claudel, T., Leibowitz, M. D., Fiévet, C., Tailleux, A., Wagner, B. L., Repa, J. J., Torpier, G., Lobaccaro, J. A., Paterniti, J. R., Mangelsdorf, D. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041609298 · Cited by 292 · see citing works

Oligomerization of RAR and AML1 Transcription Factors as a Novel Mechanism of Oncogenic Activation

Minucci, S., Maccarana, M., Cioce, M., Luca, P. D., Gelmetti, V., Segalla, S., Croce, L. D., Giavara, S., Matteucci, C., Gobbi, A., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80321-4 · Cited by 282 · see citing works

Retinoic acid receptors and cancers

Soprano, D. R., Qin, P., & Soprano, K. J. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132407 · Cited by 270 · see citing works

Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia.

Pandolfi, P. P., Alcalay, M., Fagioli, M., Zangrilli, D., Mencarelli, A., Diverio, D., Biondi, A., Coco, F. L., Rambaldi, A., & Grignani, F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05185.x · Cited by 261 · see citing works

Methylation and Silencing of the Retinoic Acid Receptor- 2 Gene in Breast Cancer

Widschwendter, M., Berger, J., Hermann, M., Muller, H. M., Amberger, A., Zeschnigk, M., Widschwendter, A., Abendstein, B. J., Zeimet, A., Daxenbichler, G., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.826 · Cited by 259 · see citing works

RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation.

Chen, J. Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E. J., Reczek, P. R., Chambon, P., & Gronemeyer, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07102.x · Cited by 256 · see citing works

Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.

Ferrara, F. F., Fazi, F., Bianchini, A., Padula, F., Gelmetti, V., Minucci, S., Mancini, M., Pelicci, P. G., Coco, F. L., & Nervi, C. (2001) · PubMed · Cited by 241 · see citing works

Arsenic trioxide, a therapeutic agent for APL

Zhang, T.-D., Chen, G., Wang, Z., Wang, Z., Chen, S., & Chen, Z. (2001) · Oncogene · doi:10.1038/sj.onc.1204762 · Cited by 231 · see citing works

All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ

Stehlin-Gaon, C., Willmann, D., Zeyer, D., Sanglier, S., Van Dorsselaer, A., Renaud, J.-P., Moras, D., & Schüle, R. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb979 · Cited by 231 · see citing works

RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable.

Krężel, W., Dupé, V., Mark, M., Dierich, A., Kastner, P., & Chambon, P. (1996) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.93.17.9010 · Cited by 231 · see citing works

Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid

Huang, C., Ma, W., Dawson, M. I., Rincón, M., Flavell, R. A., & Dong, Z. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5826 · Cited by 226 · see citing works

Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody Therapy

Takeda, K., Yamaguchi, N., Akiba, H., Kojima, Y., Hayakawa, Y., Tanner, J. E., Sayers, T. J., Seki, N., Okumura, K., Yagita∥, H., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031457 · Cited by 206 · see citing works

p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.

Shao, Z., Dawson, M. I., Li, X. S., et al. (1995) · PubMed · Cited by 202 · see citing works

Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.

Gottardis, M. M., Bischoff, E. D., Shirley, M. A., WAGONER, M., Lamph, W. W., & Heyman, R. A. (1996) · PubMed · Cited by 199 · see citing works

Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.

Anzano, M. A., Byers, S. W., Smith, J. M., et al. (1994) · PubMed · Cited by 197 · see citing works

Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.

Miller, V. A., Benedetti, F. M., Rigas, J. R., Verret, A. L., Pfister, D. G., Straus, D., Kris, M. G., Crisp, M., Heyman, R. A., Loewen, G. R., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.790 · Cited by 185 · see citing works

Oral Cancer Prevention and the Evolution of Molecular-Targeted Drug Development

Lippman, S. M., Sudbø, J., & Hong, W. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.128 · Cited by 185 · see citing works

p53 Upregulates Death Receptor 4 Expression through an Intronic p53 Binding Site

Liu, X., Yue, P., Khuri, F. R., & Sun, S.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1195 · Cited by 184 · see citing works

Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor α mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ER T2 ) in adipocytes

Imai, T., Jiang, M., Chambon, P., & METZGER, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.224 · Cited by 171 · see citing works

Proteasome Inhibition Sensitizes Hepatocellular Carcinoma Cells, But Not Human Hepatocytes, to TRAIL *

Ganten, T. M., Koschny, R., Haas, T. L., Sykora, J., Li‐Weber, M., Herzer, K., & Walczak, H. (2005) · Hepatology · doi:10.1002/hep.20807 · Cited by 170 · see citing works

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway

Wang, Y., Engels, I. H., Knee, D. A., Nasoff, M. S., Deveraux, Q. L., & Quon, K. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00113-8 · Cited by 162 · see citing works

A sumoylation site in PML/RARA is essential for leukemic transformation

Zhu, J., Zhou, J., Pérès, L., Riaucoux, F., Honoré, N., Kogan, S. C., & de Thé, H. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.005 · Cited by 156 · see citing works

Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy

Wang, S., & El‐Deiry, W. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2435285100 · Cited by 152 · see citing works

Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.

Sirchia, S. M., Ren, M., Пили, Р., Sironi, E., Somenzi, G., Ghidoni, R., Toma, S., Nicolò, G., & Sacchi, N. (2002) · PubMed · Cited by 152 · see citing works

Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.

Kuroki, T., Trapasso, F., Yendamuri, S., et al. (2003) · PubMed · Cited by 151 · see citing works

PML–RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation

Kamashev, D., Vitoux, D., & de Thé, H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032226 · Cited by 151 · see citing works

Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells

Klisovic, M. I., Maghraby, E. A., Parthun, M. R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402776 · Cited by 146 · see citing works

Conformational adaptation of agonists to the human nuclear receptor RARγ

Klaholz, B. P., Renaud, J., Mitschler, A., Zusi, C., Chambon, P., Gronemeyer, H., & Moras, D. (1998) · Nature Structural Biology · doi:10.1038/nsb0398-199 · Cited by 144 · see citing works

Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung

Mehrotra, J., Vali, M., McVeigh, M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0118 · Cited by 143 · see citing works

Tumor suppressor IRF‐1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL

Clarke, N. M., Jimenez-Lara, A. M., Voltz, E., & Gronemeyer, H. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600302 · Cited by 141 · see citing works

Therapeutic Applications for Ligands of Retinoid Receptors

Thacher, S. M., Vasudevan, J., & Chandraratna, R. A. S. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003401415 · Cited by 136 · see citing works

Retinoids in Cancer Chemoprevention

Okuno, M., Kojima, S., Matsushima‐Nishiwaki, R., Tsurumi, H., Muto, Y., Friedman, S., & Moriwaki, H. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043333023 · Cited by 133 · see citing works

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

Fenaux, P., Chomienne, C., & Degos, L. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90002-2 · Cited by 132 · see citing works

Retinoid Induced Apoptosis in Leukemia Cells Through a Retinoic Acid Nuclear Receptor-Independent Pathway

Hsu, C. A., Rishi, A. K., Su-Li, X., Gerald, T. M., Dawson, M. I., Schiffer, C. A., Reichert, U., Shroot, B., Poirier, G. G., & Fontana, J. A. (1997) · Blood · doi:10.1182/blood.v89.12.4470 · Cited by 128 · see citing works

Structural basis for isotype selectivity of the human retinoic acid nuclear receptor 1 1Edited by T. Richmond

Klaholz, B. P., Mitschler, A., & Moras, D. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4032 · Cited by 123 · see citing works

Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytesPreprint

Calleja, C., Messaddeq, N., Chapellier, B., Yang, H., Krężel, W., Li, M., METZGER, D., Mascrez, B., Ohta, K., Kagechika, H., et al. (2006) · Genes & Development · doi:10.1101/gad.368706 · Cited by 123 · see citing works

Synthesis, Structure-Affinity Relationships, and Biological Activities of Ligands Binding to Retinoic Acid Receptor Subtypes

Charpentier, B., Bernardon, J., Eustache, J., Millois, C., Martin, B., Michel, S., & Shroot, B. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00026a006 · Cited by 122 · see citing works

Targeting Nur77 translocation

Zhang, X.-K. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.1.69 · Cited by 122 · see citing works

Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment

Wang, Z., Boudjelal, M., Kang, S., Voorhees, J. J., & Fisher, G. J. (1999) · Nature Medicine · doi:10.1038/7417 · Cited by 118 · see citing works

Impairment of p53 acetylation, stability and function by an oncogenic transcription factor

Insinga, A., Monestiroli, S., Ronzoni, S., Carbone, R., Pearson, M. A., Pruneri, G., Viale, G., Appella, E., Pelicci, P. G., & Minucci, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600109 · Cited by 117 · see citing works

Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of Acute Myeloid Leukemia by Protein Kinase A–Mediated Desubordination of Retinoid X Receptor

Altucci, L., Rossin, A., Hirsch, O., Nebbioso, A., Vitoux, D., Wilhelm, E., Guidez, F., Simone, M. D., Schiavone, E. M., Grimwade, D. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3569 · Cited by 113 · see citing works

The Targeted Disruption of Both Alleles of RARβ2 in F9 Cells Results in the Loss of Retinoic Acid-associated Growth Arrest

Faria, T. N., Mendelsohn, C. L., Chambon, P., & Gudas, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26783 · Cited by 111 · see citing works

RAR‐independent RXR signaling induces t(15;17) leukemia cell maturation

Benoit, G., Altucci, L., Flexor, M., Ruchaud, S., Lillehaug, J., Raffelsberger, W., Gronemeyer, H., & Lanotte, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7011 · Cited by 111 · see citing works

RXR Is an Essential Component of the Oncogenic PML/RARA Complex In Vivo

Zhu, J., Nasr, R., Pérès, L., Riaucoux, F., Honoré, N., Berthier, C., Kamashev, D., Zhou, J., Vitoux, D., Lavau, C., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.004 · Cited by 109 · see citing works

A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3β/FBW7 loss of function

Rottmann, S., Wang, Y., Nasoff, M. S., Deveraux, Q. L., & Quon, K. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505114102 · Cited by 108 · see citing works

Differential Effects of Rexinoids and Thiazolidinediones on Metabolic Gene Expression in Diabetic Rodents

Ahuja, H. S., Liu, S., Crombie, D. L., Boehm, M. F., Leibowitz, M. D., Heyman, R. A., Depré, C., Nagy, L., Tontonoz, P., & Davies, P. J. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.765 · Cited by 108 · see citing works

IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo

Kim, P. K. M., Armstrong, M. J., Liu, Y., Yan, P., Bucher, B. T., Zuckerbraun, B. S., Gambotto, A. A., Billiar, T. R., & Yim, J. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207023 · Cited by 107 · see citing works

Methylation and silencing of the retinoic acid receptor-β2 gene in cervical cancer

Иванова, Т. А., Petrenko, A. A., Gritsko, T., et al. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-4 · Cited by 105 · see citing works

The theory of APL

Piazza, F., Gurrieri, C., & Pandolfi, P. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204855 · Cited by 105 · see citing works

Inducible Silencing of KILLER/DR5 In vivo Promotes Bioluminescent Colon Tumor Xenograft Growth and Confers Resistance to Chemotherapeutic Agent 5-Fluorouracil

Wang, S., & El‐Deiry, W. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1734 · Cited by 104 · see citing works

Thyroid hormone resistance and increased metabolic rate in the RXR-γ–deficient mouse

Brown, N. S., Smart, A., Sharma, V., Brinkmeier, M. L., Greenlee, L. F., Camper, S. A., Jensen, D. R., Eckel, R. H., Krężel, W., Chambon, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9422 · Cited by 103 · see citing works

A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands

Crowe, D. L., & Chandraratna, R. A. S. (2004) · Breast Cancer Research · doi:10.1186/bcr913 · Cited by 101 · see citing works

Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology.

Buck, J., Grün, F., Derguini, F., Chen, Y., Kimura, S., Noy, N., & Hämmerling, U. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.2.675 · Cited by 100 · see citing works

Randomized Phase II/III Trial of Interferon Alfa-2a With and Without 13-cis-Retinoic Acid in Patients With Progressive Metastatic Renal Cell Carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)

Aass, N., Mulder, P. H. M. D., Mickisch, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.114 · Cited by 100 · see citing works

In Vivo Activation of cAMP Signaling Induces Growth Arrest and Differentiation in Acute Promyelocytic Leukemia

Guillemin, M.-C., Raffoux, E., Vitoux, D., Kogan, S. C., Soilihi, H., Lallemand-Breitenbach, V., Zhu, J., Janin, A., Daniel, M., Gourmel, B., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021129 · Cited by 98 · see citing works

Recruitment of RXR by Homotetrameric RARα Fusion Proteins Is Essential for Transformation

Zeisig, B. B., Kwok, C., Zelent, A., Shankaranarayanan, P., Gronemeyer, H., Dong, S., & So, C. W. E. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.006 · Cited by 92 · see citing works

Rational design of RAR‐selective ligands revealed by RARβ crystal stucture

Germain, P., Kammerer, S., Pérez‐Santín, E., Peluso‐Iltis, C., Tortolani, D. R., Zusi, F. C., Starrett, J. E. J., Lapointe, P., Daris, J., Marinier, A., et al. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400235 · Cited by 91 · see citing works

Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists

Géhin, M., Vivat, V., Wurtz, J., Losson, R., Chambon, P., Moras, D., & Gronemeyer, H. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80084-2 · Cited by 90 · see citing works

Metabolic Effects of Rexinoids: Tissue-Specific Regulation of Lipoprotein Lipase Activity

Davies, P. J. A., Berry, S. A., Shipley, G. L., Eckel, R. H., Hennuyer, N., Crombie, D. L., Ogilvie, K. M., Peinado-Onsurbe, J., Fievet, C., Leibowitz, M. D., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.2.170 · Cited by 89 · see citing works

Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma.

Greenhalgh, D. A., Welty, D. J., Player, A. N., & Yuspa, S. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.643 · Cited by 88 · see citing works

Treatment concepts of acute promyelocytic leukemia

Lengfelder, E., Saußele, S., Weisser, A., et al. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.08.009 · Cited by 88 · see citing works

Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARγ

Klaholz, B. P., Mitschler, A., Belema, M., Zusi, C., & Moras, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6322 · Cited by 85 · see citing works

Induction of Apoptosis by Retinoids and Retinoic Acid Receptor γ-Selective Compounds in Mouse Thymocytes through a Novel Apoptosis Pathway

Szondy, Z., Reichert, U., Bernardon, J., Michel, S., Tóth, R., Ancian, P., Ajzner, É., & Fésüs, L. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.972 · Cited by 81 · see citing works

Oncogenic Ras Sensitizes Normal Human Cells to Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand-Induced Apoptosis

Nesterov, A., Nikrad, M. P., Johnson, T. R., & Kraft, A. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2219 · Cited by 80 · see citing works

Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation

Zhao, Q. C., Tao, J., Zhu, Q., Jia, P.-M., Dou, A.-X., Li, X., Cheng, F., Waxman, S., Chen, G.-Q., Chen, S.-J., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403226 · Cited by 79 · see citing works

Preliminary Observations on the Use of Topical Tazarotene to Treat Basal-Cell Carcinoma

Peris, K., Fargnoli, M. C., & Chimenti, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412312 · Cited by 78 · see citing works

Induction of the Fatty Acid Transport Protein 1 and Acyl-CoA Synthase Genes by Dimer-selective Rexinoids Suggests That the Peroxisome Proliferator-activated Receptor-Retinoid X Receptor Heterodimer Is Their Molecular Target

Martin, G., Poirier, H., Crombie, D. L., Fruchart, J., Heyman, R. A., Besnard, P., Auwerx, J. H., & Hennuyer, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12612 · Cited by 78 · see citing works

Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma

Zhang, C., & Duvic, M. A. (2003) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2003.01644.x · Cited by 78 · see citing works

Mechanism of Selective Retinoid X Receptor Agonist-Induced Hypothyroidism in the Rat

Liu, S., Ogilvie, K. M., Klausing, K., Lawson, M. A., Jolley, D., Li, D., Bilakovics, J. M., Pascual, B., Hein, N., Urcan, M. S., et al. (2002) · Endocrinology · doi:10.1210/endo.143.8.8930 · Cited by 75 · see citing works

Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases

Bianchi, L., Orlandi, A., Campione, E., Angeloni, C., Costanzo, A., Spagnoli, L. G., & Chimenti, M. S. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06044.x · Cited by 73 · see citing works

The Rexinoid LG100754 Is a Novel RXR:PPARγ Agonist and Decreases Glucose Levelsin Vivo

Cesario, R. M., Klausing, K., Razzaghi, H., Crombie, D. L., Rungta, D. K., Heyman, R. A., & Lala, D. S. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.8.0677 · Cited by 71 · see citing works

Biological Characterization of a Heterodimer-Selective Retinoid X Receptor Modulator: Potential Benefits for the Treatment of Type 2 Diabetes

Leibowitz, M. D., Ardecky, R., Boehm, M. F., Broderick, C. L., Carfagna, M. A., Crombie, D. L., D’Arrigo, J., Etgen, G. J., Faul, M. M., Grese, T. A., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0690 · Cited by 71 · see citing works

Cell cycle regulators in testicular cancer: Loss of p18INK4C marks progression from carcinomain situ to invasive germ cell tumours

Bártková, J., Thullberg, M., Meyts, E. R., Skakkebæk, N. E., & Bartek, J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3 · Cited by 70 · see citing works

Apoptosis Induction by a Novel Retinoid-Related Molecule Requires Nuclear Factor-κB Activation

Farhana, L., Dawson, M. I., & Fontana, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4124 · Cited by 69 · see citing works

Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines.

Suh, Y., Lee, H., Virmani, A. K., Wong, J., Mann, K. K., Miller, W. H., Gazdar, A. F., & Kurie, J. M. (2002) · PubMed · Cited by 64 · see citing works

F-actin as a functional target for retro-retinoids: A potential role in anhydroretinol-triggered cell death

Korichneva, I. L., & Hämmerling, U. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.15.2521 · Cited by 63 · see citing works

Inhibition of IκB Kinase by a New Class of Retinoid-Related Anticancer Agents That Induce Apoptosis

Bayón, Y., Ortiz, M. A., López-Hernández, F. J., Gao, F., Karin, M., Pfahl, M., & Piedrafita, F. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1061-1074.2003 · Cited by 63 · see citing works

A Novel Atypical Retinoid Endowed with Proapoptotic and Antitumor Activity

Cincinelli, R., Dallavalle, S., Merlini, L., Penco, S., Pisano, C., Carminati, P., Giannini, G., Vesci, L., Gaetano, C., Illy, B., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025593y · Cited by 62 · see citing works

Distinct Mechanisms of Glucose Lowering by Specific Agonists for Peroxisomal Proliferator Activated Receptor γ and Retinoic Acid X Receptors

Li, X., Hansen, P. A., Li, X., Chandraratna, R. A. S., & Burant, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505853200 · Cited by 60 · see citing works

Temporal Changes in Gene Expression in the Arcuate Nucleus Precede Seasonal Responses in Adiposity and Reproduction

Ross, A., Bell, L., Littlewood, P. A., Mercer, J. G., Barrett, P., & Morgan, P. J. (2005) · Endocrinology · doi:10.1210/en.2004-1538 · Cited by 60 · see citing works

IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo

Kröger, A., Dallügge, A., Kirchhoff, S., & Häuser, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206260 · Cited by 58 · see citing works

Retro-retinoids in regulated cell growth and death.

O’Connell, M. J., Chua, R. A., Hoyos, B. E., Buck, J., Chen, Y., Derguini, F., & Hämmerling, U. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.549 · Cited by 58 · see citing works

Topical Tazarotene Chemoprevention Reduces Basal Cell Carcinoma Number and Size in Ptch1 +/− Mice Exposed to Ultraviolet or Ionizing Radiation

So, P.-L., Lee, K. M. L., Hebert, J. L., Walker, P., Lü, Y., Hwang, J., Kopelovich, L., Athar, M., Bickers, D. R., Aszterbaum, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1927 · Cited by 57 · see citing works

The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression

Kalvakolanu, D. V. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.01.002 · Cited by 56 · see citing works

Activation of c-Raf Kinase by Ultraviolet Light

Hoyos, B., Imam, A., Korichneva, I., Levi, E., Chua, R., & Hammerling, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110750200 · Cited by 55 · see citing works

9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma

Aboulafia, D. M., Norris, D., Henry, D. H., Grossman, R. J., Thommes, J. A., Bundow, D., Yocum, R. C., & Stevens, V. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.2.178 · Cited by 55 · see citing works

Identification of Highly Potent Retinoic Acid Receptor α-Selective Antagonists

Teng, M., Duong, T. T., Johnson, A. T., Klein, E. S., Wang, L., Khalifa, B., & Chandraratna, R. A. S. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9703911 · Cited by 54 · see citing works

Retinoid X Receptor γ-Deficient Mice Have Increased Skeletal Muscle Lipoprotein Lipase Activity and Less Weight Gain when Fed a High-Fat Diet

Haugen, B. R., Jensen, D. R., Sharma, V., Pulawa, L. K., Hays, W. R., Krężel, W., Chambon, P., & Eckel, R. H. (2004) · Endocrinology · doi:10.1210/en.2003-1401 · Cited by 54 · see citing works

Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice

Shen, Q., Cline, G. W., Shulman, G. I., Leibowitz, M. D., & Davies, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311729200 · Cited by 53 · see citing works

Multiple types of aberrations in the p16 (INK4a) and the p15INK4b genes in 30 esophageal squamous‐cell‐carcinoma cell lines

Tanaka, H., Shimada, Y., Imamura, M., Shibagaki, I., & Ishizaki, K. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970207)70:4 · Cited by 52 · see citing works

Acute myeloid leukemia: Therapeutic impact of epigenetic drugs

Altucci, L., Clarke, N. M., Nebbioso, A., Scognamiglio, A., & Gronemeyer, H. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.019 · Cited by 52 · see citing works

Anhydroretinol induces oxidative stress and cell death.

Chen, Y., Buck, J., & Derguini, F. (1999) · PubMed · Cited by 52 · see citing works

The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway.

Chun, K., Benbrook, D. M., Berlin, K. D., et al. (2003) · PubMed · Cited by 50 · see citing works

Structure-Based Design of Potent Retinoid X Receptor α Agonists

Haffner, C. D., Lenhard, J. M., Miller, A. B., McDougald, D. L., Dwornik, K. A., Ittoop, O. R. R., Robert T. Gampe, Xu, H. E., Blanchard, S., Montana, V. G., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030565g · Cited by 49 · see citing works

Autonomous Rexinoid Death Signaling Is Suppressed by Converging Signaling Pathways in Immature Leukemia Cells

Benoit, G. R., Flexor, M., Besançon, F., Altucci, L., Rossin, A., Hillion, J., Balajthy, Z., Legrès, L., Ségal-Bendirdjian, E., Gronemeyer, H., et al. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.7.0654 · Cited by 48 · see citing works

Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer

Wolf, S., Mertens, D., Pscherer, A., Schroeter, P., Winkler, D. F. H., Gröne, H., Hofele, C., Hemminki, K., Kumar, R., Steineck, G., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21502 · Cited by 47 · see citing works

Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders?

Rego, E. M., & Pandolfi, P. P. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02384-5 · Cited by 47 · see citing works

A New Retinoid-Like Compound That Activates Peroxisome Proliferator-Activated Receptors and Lowers Blood Glucose in Diabetic Mice

Deng, T., Shan, S., Li, Z.-B., Wu, Z.-W., Liao, C., Ko, B. C. B., Lu, X.-P., Cheng, J., & Ning, Z.-Q. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1192 · Cited by 47 · see citing works

RARα1/RARα2-PML mRNA Expression in Acute Promyelocytic Leukemia Cells: A Molecular and Laboratory-Clinical Correlative Study

Li, Y., Andersen, J., Zelent, A., et al. (1997) · Blood · doi:10.1182/blood.v90.1.306.306_306_312 · Cited by 47 · see citing works

AP-1 and C/EBP transcription factors contribute tomda-7 gene promoter activity during human melanoma differentiation

Madireddi, M. T., Dent, P., & Fisher, P. B. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200010)185:1 · Cited by 46 · see citing works

Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a.

Berg, W. J., Nanus, D. M., Leung, A., et al. (1999) · PubMed · Cited by 46 · see citing works

The molecular biology of acute promyelocytic leukemia

Slack, J. L., & Gallagher, R. E. (2007) · Springer eBooks · doi:10.1007/978-0-585-38571-6_4 · Cited by 44 · see citing works

Topical and systemic retinoid therapy for cutaneous T-cell lymphoma

Kempf, W., Kettelhack, N., Duvic, M. A., & Burg, G. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(03)00107-2 · Cited by 43 · see citing works

Serine 232 and Methionine 272 Define the Ligand Binding Pocket in Retinoic Acid Receptor Subtypes

Ostrowski, J., Roalsvig, T., Hammer, L. A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3490 · Cited by 43 · see citing works

Antagonist Analogue of 6-[3‘-(1-Adamantyl)-4‘-hydroxyphenyl]-2-naphthalenecarboxylic Acid (AHPN) Family of Apoptosis Inducers That Effectively Blocks AHPN-Induced Apoptosis but Not Cell-Cycle Arrest

Dawson, M. I., Harris, D. L., Liu, G., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030524k · Cited by 42 · see citing works

How patients have benefited from mouse models of acute promyelocytic leukaemia

Lallemand-Breitenbach, V., Zhu, J., Kogan, S. C., Chen, Z., & de Thé, H. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1719 · Cited by 41 · see citing works

A phase II multicenter clinical trial of systemic bexarotene in psoriasis

Smit, J. V., Zeeuwen-Franssen, M. E. J., de Jong, E. M. G. J., Lambert, J. R., Roseeuw, D. I., Weert, J. D., Yocum, R. C., Stevens, V. J., & van de Kerkhof, P. C. M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2002.08.001 · Cited by 38 · see citing works

RARα1/RARα2-PML mRNA Expression in Acute Promyelocytic Leukemia Cells: A Molecular and Laboratory-Clinical Correlative Study

Li, Y., Andersen, J., Zelent, A., et al. (1997) · Blood · doi:10.1182/blood.v90.1.306 · Cited by 38 · see citing works

Phosphodiesterase IV Inhibition by Piclamilast Potentiates the Cytodifferentiating Action of Retinoids in Myeloid Leukemia Cells

Parrella, E., Gianni’, M., Cecconi, V., Nigro, E. A., Barzago, M. M., Rambaldi, A., Rochette‐Egly, C., Terao, M., & Garattini, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406530200 · Cited by 37 · see citing works

Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.

Vertuani, S., Geer, A. D., Levitsky, V., et al. (2003) · PubMed · Cited by 37 · see citing works

Phase II Trial of the Novel Retinoid, Bexarotene, and Gemcitabine Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer

Edelman, M. J., Smith, R. D., Hausner, P. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.373 · Cited by 37 · see citing works

Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid

Balasubramanian, S. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh122 · Cited by 36 · see citing works

Synthesis and biological activity of retinoic acid receptor-α specific amides

Beard, R. L., Duong, T. T., Teng, M., Klein, E. S., Standevan, A. M., & Chandraratna, R. A. S. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00647-9 · Cited by 36 · see citing works

5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells.

Yang, Q., Shan, L., Yoshimura, G., et al. (2003) · PubMed · Cited by 35 · see citing works

Activation of the Retinoid X Receptor Suppresses Appetite in the Rat

Ogilvie, K. M., Saladin, R., Nagy, T. R., Urcan, M. S., Heyman, R. A., & Leibowitz, M. D. (2003) · Endocrinology · doi:10.1210/en.2003-0907 · Cited by 34 · see citing works

Design, Synthesis, and Structure−Activity Relationship Studies of Novel 6,7-Locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic Acids

Michellys, P., Ardecky, R., Chen, J., D’Arrigo, J., Grese, T. A., Karanewsky, D. S., Leibowitz, M. D., Liu, S., Mais, D. E., Mapes, C. M., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020401k · Cited by 34 · see citing works

Breast Cancer Prevention Trials Using Retinoids

DeCensi, A., Serrano, D., Bonanni, B., et al. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025779120649 · Cited by 33 · see citing works

Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging.

Baumann, L., Vujevich, J. J., Halem, M., et al. (2005) · PubMed · Cited by 32 · see citing works

A Retinoid-Related Molecule that Does Not Bind to Classical Retinoid Receptors Potently Induces Apoptosis in Human Prostate Cancer Cells through Rapid Caspase Activation

Keedwell, R. G., Zhao, Y., Hammond, L., Qin, S., Tsang, K.-Y., Reitmair, A. H., Molina, Y., Okawa, Y., Atangan, L. I., Shurland, D., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2763 · Cited by 32 · see citing works

Discovery of Novel Retinoic Acid Receptor Agonists Having Potent Antiproliferative Activity in Cervical Cancer Cells

Zhang, L., Nadzan, A. M., Heyman, R. A., Love, D. L., Mais, D. E., Croston, G. E., Lamph, W. W., & Boehm, M. F. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960285j · Cited by 31 · see citing works

Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (Review)

Kojima, S., Okuno, M., Matsushima‐Nishiwaki, R., Friedman, S., & Moriwaki, H. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.4.797 · Cited by 30 · see citing works

The Addition of Interferon Gamma to Oral Bexarotene Therapy With Photopheresis for Sézary Syndrome

McGinnis, K. S., Ubriani, R., Newton, S. B., et al. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.9.1176 · Cited by 28 · see citing works

Activity of interferon‐α and isotretinoin in patients with advanced, refractory lymphoid malignancies

Tsimberidou, A. M., Giles, F. J., Romaguera, J. E., et al. (2004) · Cancer · doi:10.1002/cncr.20009 · Cited by 28 · see citing works

Association of death receptor 4 haplotype 626C–683C with an increased breast cancer risk

Frank, B., Hemminki, K., Shanmugam, K. S., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi164 · Cited by 27 · see citing works

An antagonist of retinoic acid receptors more effectively inhibits growth of human prostate cancer cells than normal prostate epithelium

Keedwell, R. G., Zhao, Y., Hammond, L., Wen, K., Qin, S., Atangan, L. I., Shurland, D.-L., Wallace, D. M. A., Bird, R., Reitmair, A. H., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602024 · Cited by 26 · see citing works

Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity

Adams, J., Heavens, D., Bass, S., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.052 · Cited by 25 · see citing works

The Antidiabetic Agent LG100754 Sensitizes Cells to Low Concentrations of Peroxisome Proliferator-activated Receptor γ Ligands

FORMAN, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200004200 · Cited by 24 · see citing works

Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro

Eliason, J. F., Kaufmann, F., Tanaka, T., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.240 · Cited by 23 · see citing works

Combined in vitro anti-tumoral action of tamoxifen and retinoic acid derivatives in hepatoma cells

Herold, C., Ganslmayer, M., Ocker, M., et al. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.1.89 · Cited by 23 · see citing works

Novel retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cells

Um, S., Han, H., Kwon, Y., Park, S., Rho, Y., Sin, H., & Park, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11489 · Cited by 21 · see citing works

Fenretinide and risk reduction of second breast cancer

DeCensi, A., Zanardi, S., Argusti, A., Bonanni, B., Costa, A., & Veronesi, U. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0735 · Cited by 21 · see citing works

Bexarotene in Combination with Chemotherapy Fails to Prolong Survival in Patients with Advanced Non–Small- Cell Lung Cancer: Results from the SPIRIT I and II Trials

Tyagi, P., Belani, C. P., & Jain, V. K. (2005) · Clinical Lung Cancer · doi:10.1016/s1525-7304(11)70385-0 · Cited by 21 · see citing works

Retinoic acid determines life span of leukemic cells by inducing antagonistic apoptosis-regulatory programs

Yin, W., Raffelsberger, W., & Gronemeyer, H. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.03.003 · Cited by 20 · see citing works

Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.

Recchia, F., Saggio, G., Cesta, A., et al. (2005) · PubMed · Cited by 19 · see citing works

Progress in chemoprevention of breast cancer

Serrano, D., Perego, E., Costa, A., et al. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00157-4 · Cited by 18 · see citing works

Chemoprevention of hepatocellular carcinoma: Use of tamoxifen in an animal model of hepatocarcinogenesis

Bisceglie, A. M. D., Osmack, P., & Brunt, E. M. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.01.003 · Cited by 18 · see citing works

A retinoid X receptor antagonist, HX531, improves leptin resistance without increasing plasma leptin level in KK-Ay mice under normal dietary conditions

Yotsumoto, T., Naitoh, T., Kanaki, T., & Tsuruzoe, N. (2005) · Metabolism · doi:10.1016/j.metabol.2004.11.013 · Cited by 16 · see citing works

Concurrent translocations ofMLL andCBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia

Mathew, S., Head, D., Rubnitz, J. E., & Raimondi, S. C. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200006)28:2 · Cited by 16 · see citing works

4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor α agonists

Dawson, M. I., Jong, L., Hobbs, P. D., Xiao, D., Feng, K.-C., Chao, W., Pan, C., Fontana, J. A., & Zhang, X.-K. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00244-4 · Cited by 13 · see citing works

Programmed cell death (PCD) associated with the stilbene motif of arotinoids: discovery of novel apoptosis inducer agents possessing activity on multidrug resistant tumor cells

Simoni, D., Roberti, M., Invidiata, F. P., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00547-3 · Cited by 12 · see citing works

Structural modifications of 6-naphthalene-2-carboxylate retinoids

Yu, K., Ostrowski, J., Chen, S. D. M., et al. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(96)00524-0 · Cited by 7 · see citing works

Network-based prediction of human tissue-specific metabolism

Shlomi, T., Cabili, M. N., Herrgård, M. J., Palsson, B. Ø., & Ruppin, E. (2008) · Nature Biotechnology · doi:10.1038/nbt.1487 · Cited by 637 · see citing works

Retinoic acid receptors: From molecular mechanisms to cancer therapy

di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403 · see citing works

Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids

Álvarez, R., Vaz, B., Gronemeyer, H., & de Lera, Á. R. (2014) · Chemical Reviews · doi:10.1021/cr400126u · Cited by 260 · see citing works

Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine

Ferreira, R., Napoli, J., Enver, T., Bernardino, L., & Ferreira, L. (2020) · Nature Communications · doi:10.1038/s41467-020-18042-2 · Cited by 138 · see citing works

Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression

Núñez, V., Alameda, D., Rico, D., Mota, R., Gonzalo, P., Cedenilla, M., Fischer, T., Boscá, L., Glass, C. K., Arroyo, A. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913545107 · Cited by 133 · see citing works

Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil

D'Amore, S., Vacca, M., Cariello, M., Graziano, G., D'Orazio, A., Salvia, R., Sasso, R. C., Sabbà, C., Palasciano, G., & Moschetta, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.003 · Cited by 107 · see citing works

Towards Retinoid Therapy for Alzheimers Disease

Shudo, K., Fukasawa, H., Nakagomi, M., & Yamagata, N. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486581 · Cited by 91 · see citing works

Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics

Mendoza‐Parra, M. A., Walia, M., Sankar, M., & Gronemeyer, H. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.73 · Cited by 91 · see citing works

Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations

le Maire, A., Teyssier, C., Balaguer, P., Bourguet, W., & Germain, P. (2019) · Cells · doi:10.3390/cells8111392 · Cited by 88 · see citing works

Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer’s Disease

Chakrabarti, M., McDonald, A. J., Will Reed, J., Moss, M. A., Das, B. C., & Ray, S. K. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150450 · Cited by 57 · see citing works

Synergistic effect of co-treatment with all-trans retinoic acid and 9-cis retinoic acid on human lung cancer cell line at molecular level

Bama, E. S., Grace, V. M. B., Sundaram, V., & Jesubatham, P. D. (2019) · 3 Biotech · doi:10.1007/s13205-019-1692-x · Cited by 8 · see citing works

Ligand Screening System for the RXRα Heterodimer Using the Fluorescence RXR Agonist CU-6PMN

Kawasaki, M., Motoyama, T., Yamada, S., et al. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00509 · Cited by 1 · see citing works

Assessment of Novel Rexinoids for Therapeutic Potential in Combating Alzheimer's Disease

Pedroza, M. A., Mallick, S., Marshall, P. W., et al. (2020) · The FASEB Journal · doi:10.1096/fasebj.2020.34.s1.09060

Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor‐Selective Agonists: Novel Halogenated Analogues of 4‐[1‐(3,5,5,8,8‐Pentamethyl‐5,6,7,8‐tetrahydro‐2‐naphthyl)ethynyl]benzoic Acid (Bexarotene)

Furmick, J. K., Kaneko, I., Walsh, A. N., Yang, J. C., Bhogal, J. S., Gray, G. M., Baso, J. C., Browder, D. O., Prentice, J. L. S., Montano, L. A., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200319 · Cited by 24 · see citing works

A Naturally Occurring Rexinoid, Honokiol, Can Serve as a Regulator of Various Retinoid X Receptor Heterodimers

Kotani, H., Tanabe, H., Mizukami, H., Amagaya, S., & Inoue, M. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.1 · Cited by 35 · see citing works

Development of Novel Bexarotene Analogs for Treating Cutaneous T‐Cell Lymphomas

Warda, A., Staniszewski, L. J. P., Sabir, Z. L., et al. (2021) · The FASEB Journal · doi:10.1096/fasebj.2021.35.s1.04737